FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Will Obama tax reforms quash outsourcing?

Tools

Indian pharma companies worry that President Obama's tax plans could force U.S. drugmakers to cut back on outsourcing, which would cut into their contract manufacturing and API business substantially, the Times of India writes. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about India   Pharma outsourcing   Obama Administration